Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacology|April 1, 1983
Effects of oxaprozin alone or in combination with aspirin on hemostasis and plasma protein bindingS B Kahn, J A HubsherArchives of Pathology & Laboratory Medicine|May 1, 1979
Legionnaires' disease: ultrastructural appearance of the agent in a lung biopsy specimenS M Katz, I Brodsky, S B KahnJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1992
Quality of life and patients with cancer: a comparative study of patient versus physician perceptions and its implications for cancer educationS B Kahn, P S Houts, S P HardingCancer Research|January 1, 1976
Red blood cell metabolism in AKR mice in the prelymphomatous phaseS B Kahn, T Cheung, R Lodise, et al.Cancer Clinical Trials|January 1, 1981
Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemiaP A Cassileth, S B Kahn, R Silber, et al.American Journal of Clinical Oncology|February 1, 1987
Amsacrine [4'-(9-acridinylamino)-methanesulfon-m-anisidide] (m-AMSA) and 5-azacytidine (AZA) for remission reinduction in patients with relapsed adult acute nonlymphocytic leukemia. An ECOG pilot study. Eastern Cooperative Oncology GroupS B Kahn, A Spiers, W H Knospe, et al.Clinical Nephrology|November 1, 1992
RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapyA B Schwartz, S B Kahn, B Kelch, et al.American Journal of Clinical Oncology|August 1, 1983
4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemiaS B Kahn, R Sklaroff, J Lebedda, et al.Cancer|November 15, 1986
Unmet psychological, social, and economic needs of persons with cancer in PennsylvaniaP S Houts, J M Yasko, S B Kahn, et al.Transplantation Proceedings|April 1, 1991
Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietinA B Schwartz, J E Prior, G S Mintz, et al.Pageof 3